Literature DB >> 25127672

Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

A Mieczkowska1, S Mansur, B Bouvard, P R Flatt, B Thorens, N Irwin, D Chappard, G Mabilleau.   

Abstract

UNLABELLED: A role for gut hormone in bone physiology has been suspected. We evidenced alterations of microstructural morphology (trabecular and cortical) and bone strength (both at the whole-bone--and tissue-level) in double incretin receptor knock-out (DIRKO) mice as compared to wild-type littermates. These results support a role for gut hormones in bone physiology.
INTRODUCTION: The two incretins, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), have been shown to control bone remodeling and strength. However, lessons from single incretin receptor knock-out mice highlighted a compensatory mechanism induced by elevated sensitivity to the other gut hormone. As such, it is unclear whether the bone alterations observed in GIP or GLP-1 receptor deficient animals resulted from the lack of a functional gut hormone receptor, or by higher sensitivity for the other gut hormone. The aims of the present study were to investigate the bone microstructural morphology, as well as bone tissue properties, in double incretin receptor knock-out (DIRKO) mice.
METHODS: Twenty-six-week-old DIRKO mice were age- and sex-matched with wild-type (WT) littermates. Bone microstructural morphology was assessed at the femur by microCT and quantitative X-ray imaging, while tissue properties were investigated by quantitative backscattered electron imaging and Fourier-transformed infrared microscopy. Bone mechanical response was assessed at the whole-bone- and tissue-level by 3-point bending and nanoindentation, respectively.
RESULTS: As compared to WT animals, DIRKO mice presented significant augmentations in trabecular bone mass and trabecular number whereas bone outer diameter, cortical thickness, and cortical area were reduced. At the whole-bone-level, yield stress, ultimate stress, and post-yield work to fracture were significantly reduced in DIRKO animals. At the tissue-level, only collagen maturity was reduced by 9 % in DIRKO mice leading to reductions in maximum load, hardness, and dissipated energy.
CONCLUSIONS: This study demonstrated the critical role of gut hormones in controlling bone microstructural morphology and tissue properties.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25127672     DOI: 10.1007/s00198-014-2845-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.

Authors:  Bernardo Nuche-Berenguer; Sergio Portal-Núñez; Paola Moreno; Nieves González; Alicia Acitores; Ana López-Herradón; Pedro Esbrit; Isabel Valverde; María L Villanueva-Peñacarrillo
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing.

Authors:  L M McNamara; A G H Ederveen; C G Lyons; C Price; M B Schaffler; H Weinans; P J Prendergast
Journal:  Bone       Date:  2006-04-27       Impact factor: 4.398

3.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

Authors:  L A Scrocchi; T J Brown; N MaClusky; P L Brubaker; A B Auerbach; A L Joyner; D J Drucker
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

4.  Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.

Authors:  Ding Xie; Qing Zhong; Ke-Hong Ding; Hua Cheng; Sandra Williams; Daniel Correa; Wendy B Bollag; Roni J Bollag; Karl Insogna; Nancy Troiano; Chistiane Coady; Mark Hamrick; Carlos M Isales
Journal:  Bone       Date:  2007-01-20       Impact factor: 4.398

5.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Authors:  B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

Authors:  Nathalie Pamir; Francis C Lynn; Alison M J Buchan; Jan Ehses; Simon A Hinke; J Andrew Pospisilik; Kazumasa Miyawaki; Yuichiro Yamada; Yutaka Seino; Christopher H S McIntosh; Raymond A Pederson
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-01-21       Impact factor: 4.310

7.  Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor.

Authors:  Guillaume Mabilleau; Aleksandra Mieczkowska; Nigel Irwin; Peter R Flatt; Daniel Chappard
Journal:  J Endocrinol       Date:  2013-09-06       Impact factor: 4.286

8.  Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.

Authors:  R A Pederson; M Satkunarajah; C H McIntosh; L A Scrocchi; D Flamez; F Schuit; D J Drucker; M B Wheeler
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

9.  Ultrastructural properties in cortical bone vary greatly in two inbred strains of mice as assessed by synchrotron light based micro- and nano-CT.

Authors:  Philipp Schneider; Martin Stauber; Romain Voide; Marco Stampanoni; Leah Rae Donahue; Ralph Müller
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

10.  Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(-/-) mice.

Authors:  Holly E Bates; Jonathan E Campbell; John R Ussher; Laurie L Baggio; Adriano Maida; Yutaka Seino; Daniel J Drucker
Journal:  Diabetes       Date:  2011-10-31       Impact factor: 9.461

View more
  8 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism.

Authors:  Qiu Yang; Bing Fu; Dan Luo; Haibo Wang; Hongyi Cao; Xiang Chen; Li Tian; Xijie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

Review 3.  New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders.

Authors:  Nigel Irwin; Peter R Flatt
Journal:  World J Diabetes       Date:  2015-11-10

4.  Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.

Authors:  Nan Lu; Hanxiao Sun; JingJia Yu; Xiaojing Wang; Dongmei Liu; Lin Zhao; Lihao Sun; Hongyan Zhao; Bei Tao; Jianmin Liu
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.

Authors:  Marie Pereira; Stephanie Gohin; Jean-Paul Roux; Amy Fisher; Mark E Cleasby; Guillaume Mabilleau; Chantal Chenu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-20       Impact factor: 5.555

Review 6.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

Review 7.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 8.  The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.

Authors:  Chenhe Zhao; Jing Liang; Yinqiu Yang; Mingxiang Yu; Xinhua Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-03       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.